Open AccessPREEMPTIVE THERAPY VS VALGANCICLOVIR PROPHYLAXIS FOR CYTOMEGALOVIRUS PREVENTION IN KIDNEY TRANSPLANT RECIPIENTS RECEIVING ALEMTUZUMAB INDUCTION.
Author(s) -
AUTHOR_ID
Publication year - 2006
Publication title -
transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/00007890-200607152-01544
Subject(s) - valganciclovir , alemtuzumab , medicine , cytomegalovirus , kidney transplant , induction therapy , kidney transplantation , ganciclovir , immunology , kidney , transplantation , human cytomegalovirus , human immunodeficiency virus (hiv) , virus , chemotherapy , viral disease , herpesviridae